The DOI matches its Crossref record; 187 of the 187 references it cites were found in a registry or an index.
Basics and Recent Advances in Peptide and Protein Drug Delivery
Open accessAbstract
While the peptide and protein therapeutic market has developed significantly in the past decades, delivery has limited their use. Although oral delivery is preferred, most are currently delivered intravenously or subcutaneously due to degradation and limited absorption in the gastrointestinal tract. Therefore, absorption enhancers, enzyme inhibitors, carrier systems and stability enhancers are being studied to facilitate oral peptide delivery. Additionally, transdermal peptide delivery avoids the issues of the gastrointestinal tract, but also faces absorption limitations. Due to proteases, opsonization and agglutination, free peptides are not systemically stable without modifications. This review discusses oral and transdermal peptide drug delivery, focusing on barriers and solutions to absorption and stability issues. Methods to increase systemic stability and site-specific delivery are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., & Behr, J. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,247
Intestinal mucosal barrier function in health and disease
Turner, J. R. (2009) · Nature reviews. Immunology · doi:10.1038/nri2653 · Cited by 3,952
Biodegradable polymeric nanoparticles based drug delivery systems
Kumari, A., Yadav, S. K., & Yadav, S. C. (2010) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2009.09.001 · Cited by 3,724
Prausnitz, M. R., & Langer, R. (2008) · Nature Biotechnology · doi:10.1038/nbt.1504 · Cited by 3,517
Fischer, D., Li, Y., Ahlemeyer, B., Krieglstein, J., & Kissel, T. (2003) · Biomaterials · doi:10.1016/s0142-9612(02)00445-3 · Cited by 2,329
ACIDIFICATION OF THE ENDOCYTIC AND EXOCYTIC PATHWAYS
Mellman, I., Fuchs, R., & Helenius, A. (1986) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.55.070186.003311 · Cited by 2,032
Applications of Carbon Nanotubes in Drug Delivery
Kaur, J., Gill, G. S., & Jeet, K. (2019) · Characterization and Biology of Nanomaterials for Drug Delivery · doi:10.1016/b978-0-12-814031-4.00005-2 · Cited by 2,019
The Future of Peptide‐based Drugs
Craik, D. J., Fairlie, D. P., Liras, S., & Price, D. (2013) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12055 · Cited by 1,979
Artursson, P., & Karlsson, J. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91647-u · Cited by 1,893
Wadia, J. S., Stan, R. V., & Dowdy, S. F. (2004) · Nature Medicine · doi:10.1038/nm996 · Cited by 1,647
Endosomal escape pathways for delivery of biologicals
Varkouhi, A. K., Scholte, M., Storm, G., & Haisma, H. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.004 · Cited by 1,561
Synthetic therapeutic peptides: science and market
Vlieghe, P., Lisowski, V., Martinez, J., & Khrestchatisky, M. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2009.10.009 · Cited by 1,476
The 500 Dalton rule for the skin penetration of chemical compounds and drugs
Bos, J. D., & Meinardi, M. M. H. M. (2000) · Experimental Dermatology · doi:10.1034/j.1600-0625.2000.009003165.x · Cited by 1,465
Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix
Walensky, L. D., Kung, A. L., Escher, I., Malia, T. J., Barbuto, S., Wright, R. D., Wagner, G., Verdine, G. L., & Korsmeyer, S. J. (2004) · Science · doi:10.1126/science.1099191 · Cited by 1,349
Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
Lammers, T., Kiessling, F., Hennink, W. E., & Storm, G. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.063 · Cited by 1,324
Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,125
Pantarotto, D., Briand, J.-P., Prato, M., & Bianco, A. (2004) · Chemical Communications · doi:10.1039/b311254c · Cited by 1,102
Carbon Nanotubes as Intracellular Protein Transporters: Generality and Biological Functionality
Kam, N. W. S., & Dai, H. (2005) · Journal of the American Chemical Society · doi:10.1021/ja050062v · Cited by 1,047
Schafmeister, C. E., Po, J., & Verdine, G. L. (2000) · Journal of the American Chemical Society · doi:10.1021/ja000563a · Cited by 1,037
Mechanisms of Cellular Uptake of Cell-Penetrating Peptides
Madani, F., Lindberg, S., Langel, Ü., Futaki, S., & Gräslund, A. (2011) · Journal of Biophysics · doi:10.1155/2011/414729 · Cited by 984
Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency
Jani, P., Halbert, G. W., Langridge, J., & Florence, A. T. (1990) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1990.tb07033.x · Cited by 920
Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system
Storm, G., Belliot, S. O., Daemen, T., & Lasic, D. D. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00039-a · Cited by 877
Effective drug delivery by PEGylated drug conjugates
Greenwald, R. B., Choe, Y. H., McGuire, J., & Conover, C. D. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00180-1 · Cited by 869
Biologically erodable microspheres as potential oral drug delivery systems
Mathiowitz, E., Jacob, J. S., Jong, Y. S., Carino, G. P., Chickering, D. E., Chaturvedi, P., Santos, C. A., Vijayaraghavan, K., Montgomery, S., Bassett, M., et al. (1997) · Nature · doi:10.1038/386410a0 · Cited by 823
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
Jiang, T., Olson, E. S., Nguyen, Q. T., Roy, M., Jennings, P. A., & Tsien, R. Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408191101 · Cited by 822
Cell-penetrating peptides: mechanism and kinetics of cargo delivery
Zorko, M., & Langel, Ü. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.10.010 · Cited by 799
Torchilin, V. P., Rammohan, R., Weissig, V., & Levchenko, T. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151247498 · Cited by 777
Approaches for enhancing oral bioavailability of peptides and proteins
Renukuntla, J., Vadlapudi, A. D., Patel, A., Boddu, S. H. S., & Mitra, A. K. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.030 · Cited by 681 · cited 1×
“First, they can disrupt the normal absorption of dietary peptides and may induce toxic shock after prolonged therapy [63,64].”
Alginate/Chitosan Nanoparticles are Effective for Oral Insulin Delivery
Sarmento, B., Ribeiro, A., Veiga, F., Sampaio, P., Neufeld, R., & Ferreira, D. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9367-4 · Cited by 617
Thiomers: A new generation of mucoadhesive polymers
BERNKOPSCHNURCH, A. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.07.002 · Cited by 610
Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition
Zhou, S.-F. (2008) · Xenobiotica · doi:10.1080/00498250701867889 · Cited by 599
ABC Efflux Pump-Based Resistance to Chemotherapy Drugs
Eckford, P. D. W., & Sharom, F. J. (2009) · Chemical Reviews · doi:10.1021/cr9000226 · Cited by 597
Jung, T. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00084-9 · Cited by 588
Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions.
Fasano, A., Baudry, B., Pumplin, D. W., Wasserman, S. S., Tall, B. D., Ketley, J. M., & Kaper, J. B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5242 · Cited by 579
Kim, S., Shi, Y., Kim, J. Y., Park, K., & Cheng, J.-X. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903380446 · Cited by 549
Delivery of Therapeutic Proteins
Pisal, D. S., Kosloski, M. P., & Balu-Iyer, S. V. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22054 · Cited by 532
Skin electroporation for transdermal and topical delivery
Denet, A.-R., Vanbever, R., & Préat, V. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.027 · Cited by 531
Is the oral route possible for peptide and protein drug delivery?
Morishita, M., & Peppas, N. A. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.08.005 · Cited by 515 · cited 1×
“This system can be used to encapsulate peptides and proteins and thereby protect them against enzymatic degradation [126].”
Oral Delivery of Peptide Drugs: Barriers and Developments
Hamman, J. H., Enslin, G. M., & Kotz??, A. F. (2005) · BioDrugs · doi:10.2165/00063030-200519030-00003 · Cited by 499
Buccal Mucosa as A Route for Systemic Drug Delivery: A Review
Patel, D. A., Patel, M., Patel, K. R., et al. (2012) · International Journal of Drug Development and Research · Cited by 499
On the formulation of pH-sensitive liposomes with long circulation times
Simões, S. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.038 · Cited by 483
Gabizon, A., & Martin, F. (1997) · Drugs · doi:10.2165/00003495-199700544-00005 · Cited by 478
Effect of Chitosan on Epithelial Cell Tight Junctions
Smith, J., Wood, E., & Dornish, M. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000012150.60180.e3 · Cited by 467
Micro-scale devices for transdermal drug delivery
Arora, A., Prausnitz, M. R., & Mitragotri, S. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.08.032 · Cited by 464
Wyman, T. B., Nicol, F., Zelphati, O., Scaria, P. V., Plank, C., & Szoka, F. C. (1997) · Biochemistry · doi:10.1021/bi9618474 · Cited by 453
First-Pass Elimination: Basic Concepts and Clinical Consequences
Pond, S. M., & Tozer, T. N. (1984) · Clinical Pharmacokinetics · doi:10.2165/00003088-198409010-00001 · Cited by 450
Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody
Kocbek, P., Obermajer, N., Cegnar, M., Kos, J., & Kristl, J. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.03.012 · Cited by 436
Stapled Peptides for Intracellular Drug Targets
Verdine, G. L., & Hilinski, G. J. (2012) · Methods in Enzymology · doi:10.1016/b978-0-12-396962-0.00001-x · Cited by 433
Nasal drug delivery: new developments and strategies
Illum, L. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02529-1 · Cited by 431
Chitosan and its derivatives as intestinal absorption enhancers
Thanou, M., Verhoef, J. C., & Junginger, H. E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00180-6 · Cited by 430
Miller, S. M., Simon, R. J., Ng, S., Zuckermann, R. N., Kerr, J. M., & Moos, W. H. (1995) · Drug Development Research · doi:10.1002/ddr.430350105 · Cited by 429
Polymeric protein delivery systems
Lee, K. Y., & Yuk, S. H. (2007) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.04.001 · Cited by 425
Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome–DNA complexes
Torchilin, V. P., Levchenko, T. S., Rammohan, R., Volodina, N., Papahadjopoulos-Sternberg, B., & D'Souza, G. G. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0435906100 · Cited by 419
Lectin-mediated drug targeting: history and applications
Bies, C., Lehr, C.-M., & Woodley, J. F. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.030 · Cited by 414
The lung as a route for systemic delivery of therapeutic proteins and peptides
Uchenna Agu, R., Ikechukwu Ugwoke, M., Armand, M., Kinget, R., & Verbeke, N. (2001) · Respiratory Research · doi:10.1186/rr58 · Cited by 411
The Uptake and Translocation of Latex Nanospheres and Microspheres after Oral Administration to Rats
Jani, P., Halbert, G. W., Langridge, J., & Florence, A. T. (1989) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1989.tb06377.x · Cited by 394
pH stability and activity curves of pepsin with special reference to their clinical importance.
Piper, D. W., & Fenton, B. H. (1965) · Gut · doi:10.1136/gut.6.5.506 · Cited by 385
Schipper, N. G. M., Vårum, K. M., & Artursson, P. (1996) · Pharmaceutical Research · doi:10.1023/a:1016444808000 · Cited by 384
Tobı́o, M., Sánchez, A., Vila, A., Soriano, I., Evora, C., Vila-Jato, J. L., & Alonso, M. J. (2000) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00157-5 · Cited by 368
Nanoemulsion: A pharmaceutical review
Shah, P., Bhalodia, D., & Shelat, P. (2010) · Systematic Reviews in Pharmacy · doi:10.4103/0975-8453.59509 · Cited by 368
Peptide and protein drug delivery to and into tumors: challenges and solutions
Torchilin, V. P., & Lukyanov, A. N. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02623-0 · Cited by 363
Emerging Trends in Oral Delivery of Peptide and Protein Drugs
Mahato, R. I., Narang, A. S., Thoma, L., & Miller, D. D. (2003) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v20.i23.30 · Cited by 352
Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats
Damgé, C., Maincent, P., & Ubrich, N. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.023 · Cited by 351
McMartin, C., Hutchinson, L. E. F., Hyde, R., & Peters, G. E. (1987) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600760709 · Cited by 349
Carino, G. P., & Mathiowitz, E. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00075-1 · Cited by 347
Fasano, A., Fiorentini, C., Donelli, G., Uzzau, S., Kaper, J. B., Margaretten, K., Ding, X., Guandalini, S., Comstock, L., & Goldblum, S. E. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118114 · Cited by 342
Shenoy, D. B., & Amiji, M. M. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.12.010 · Cited by 331
Phospholipids and Lipid-Based Formulations in Oral Drug Delivery
Fricker, G., Kromp, T., Wendel, A., Blume, A., Zirkel, J., Rebmann, H., Setzer, C., Quinkert, R.-O., Martin, F., & Müller-Goymann, C. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0130-x · Cited by 326
Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase.
Chen, J.-M., Dando, P. M., Rawlings, N. D., Brown, M. A., Young, N. E., Stevens, R. A., Hewitt, E., Watts, C., & Barrett, A. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.8090 · Cited by 320
Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery
MAE, M., & LANGEL, U. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.04.004 · Cited by 317
Bernkop-Schnürch, A. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00204-6 · Cited by 309
Koren, E., Apte, A., Jani, A., & Torchilin, V. P. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.002 · Cited by 293
Gabizón, A., & Martin, F. J. (1997) · Drugs · Cited by 293
Chitosans as absorption enhancers of poorly absorbable drugs
Schipper, N. G. M., Vårum, K. M., Stenberg, P., Ocklind, G., Lennernäs, H., & Artursson, P. (1999) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(99)00032-9 · Cited by 278
Polyethylene glycol–superoxide dismutase, a conjugate in search of exploitation
Veronese, F. M., Caliceti, P., Schiavon, O., & Sergi, M. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00029-7 · Cited by 273
Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis
Jo, D., Liu, D., Yao, S., Collins, R. D., & Hawiger, J. (2005) · Nature Medicine · doi:10.1038/nm1269 · Cited by 271
Chemical Penetration Enhancers for Transdermal Drug Delivery Systems
Pathan, I., & Setty, C. (2009) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v8i2.44527 · Cited by 270
Ishida, T., Ichihara, M., Wang, X., & Kiwada, H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.001 · Cited by 270
Silhol, M., Tyagi, M., Giacca, M., Lebleu, B., & Vivès, E. (2002) · European Journal of Biochemistry · doi:10.1046/j.0014-2956.2001.02671.x · Cited by 268
Fasano, A., & Uzzau, S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119271 · Cited by 266
Ziegler, A., Nervi, P., Dürrenberger, M., & Seelig, J. (2005) · Biochemistry · doi:10.1021/bi0491604 · Cited by 266
Oral protein delivery: Current status and future prospect
Park, K., Kwon, I. C., & Park, K. (2011) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2010.10.002 · Cited by 266
Absorption Enhancers for Nasal Drug Delivery
Davis, S. S., & Illum, L. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342130-00003 · Cited by 264
Tugyi, R., Uray, K., Iván, D., Fellinger, E., Perkins, A., & Hudecz, F. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407677102 · Cited by 264
Protein and peptide drug delivery: Oral approaches
Shaji, J., & Patole, V (2008) · Indian Journal of Pharmaceutical Sciences · doi:10.4103/0250-474x.42967 · Cited by 262
Paclitaxel-Loaded Gelatin Nanoparticles for Intravesical Bladder Cancer Therapy
Lu, Z., Yeh, T.-K., Tsai, M., Au, J. L.-S., & Wientjes, M. G. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1443 · Cited by 256
Buccal mucosa as a route for systemic drug delivery: a review.
Shojaei, A. H. (2000) · PubMed · Cited by 253
Intestinal Permeability Enhancement: Efficacy, Acute Local Toxicity, and Reversibility
Swenson, E. S., Milisen, W. B., & Curatolo, W. (1994) · Pharmaceutical Research · doi:10.1023/a:1018984731584 · Cited by 251
Chitosan and its derivatives: potential excipients for peroral peptide delivery systems
Bernkop-Schnürch, A. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00365-8 · Cited by 250
Transdermal protein delivery by a coadministered peptide identified via phage display
Chen, Y., Shen, Y., Guo, X., Zhang, C., Yang, W., Ma, M., Liu, S., Zhang, M., & Wen, L.-P. (2006) · Nature Biotechnology · doi:10.1038/nbt1193 · Cited by 249
Protease-Activated Drug Development
Choi, K. Y., Swierczewska, M., Lee, S., & Chen, X. (2012) · Theranostics · doi:10.7150/thno.4068 · Cited by 245
Polyethylene glycol-conjugated pharmaceutical proteins
Bailon, P., & Berthold, W. (1998) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(98)00086-8 · Cited by 243
Cell-Penetrating Peptides: Mechanisms and Applications
El-Andaloussi, S., Holm, T., & Langel, U. (2005) · Current Pharmaceutical Design · doi:10.2174/138161205774580796 · Cited by 242
Introduction and overview of peptide and protein pegylation
(2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00020-0 · Cited by 235
Improvement of oral peptide bioavailability: Peptidomimetics and prodrug strategies
Pauletti, G. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00045-8 · Cited by 233
A novel vitamin B12-nanosphere conjugate carrier system for peroral delivery of insulin
Chalasani, K. B., Russell-Jones, G. J., Yandrapu, S. K., Diwan, P. V., & Jain, S. K. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.12.003 · Cited by 228
Ogris, M., Carlisle, R. C., Bettinger, T., & Seymour, L. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108331200 · Cited by 225
Bernkop-Schnürch, A. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00136-3 · Cited by 223
Mitosis enhances transgene expression of plasmid delivered by cationic liposomes
Tseng, W.-C., Haselton, F. R., & Giorgio, T. D. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00039-1 · Cited by 221
Transdermal Delivery of Molecules is Limited by Full Epidermis, Not Just Stratum Corneum
Andrews, S. N., Jeong, E., & Prausnitz, M. R. (2013) · Pharmaceutical Research · doi:10.1007/s11095-012-0946-7 · Cited by 216
Anderberg, E. K., Nyström, C., & Artursson, P. (1992) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600810908 · Cited by 214
Basu, A., Yang, K., Wang, M., Liu, S., Chintala, R., Palm, T., Zhao, H., Peng, P., Wu, D., Zhang, Z., et al. (2006) · Bioconjugate Chemistry · doi:10.1021/bc050322y · Cited by 213
Octaarginine-modified multifunctional envelope-type nano device for siRNA
Nakamura, Y., Kogure, K., Futaki, S., & Harashima, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.03.010 · Cited by 201
Lindmark, T., Nikkilä, T., & Artursson, P. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12150-2 · Cited by 200
The Pharmacokinetics of Cell-Penetrating Peptides
Sarko, D., Beijer, B., Garcia Boy, R., Nothelfer, E.-M., Leotta, K., Eisenhut, M., Altmann, A., Haberkorn, U., & Mier, W. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100223d · Cited by 199
Structural requirements for intestinal absorption of peptide drugs
Pauletti, G. M., Gangwar, S., Knipp, G. T., Nerurkar, M. M., Okumu, F. W., Tamura, K., Siahaan, T. J., & Borchardt, R. T. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(96)01352-1 · Cited by 198
Webster, R., Elliott, V., Park, B. K., Walker, D., Hankin, M., & Taupin, P. (2009) · PEGylated Protein Drugs: Basic Science and Clinical Applications · doi:10.1007/978-3-7643-8679-5_8 · Cited by 187
Mechanisms of absorption enhancement and tight junction regulation
Hochman, J., & Artursson, P. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90072-8 · Cited by 186
Intracellular delivery of protein and peptide therapeutics
Torchilin, V. (2008) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2009.01.002 · Cited by 180
Usefulness of cell-penetrating peptides to improve intestinal insulin absorption
Kamei, N., Morishita, M., Eda, Y., Ida, N., Nishio, R., & Takayama, K. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.08.001 · Cited by 177
Transdermal Delivery of Proteins
Kalluri, H., & Banga, A. K. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-011-9601-6 · Cited by 176
Mastrobattista, E., Koning, G. A., van Bloois, L., Filipe, A. C. S., Jiskoot, W., & Storm, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200429200 · Cited by 173
Oral biodrug delivery using cell-penetrating peptide
Khafagy, E.-S., & Morishita, M. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.014 · Cited by 173
Cano-Cebrian, M., Zornoza, T., Granero, L., & Polache, A. (2005) · Current Drug Delivery · doi:10.2174/1567201052772834 · Cited by 171
Weissig, V., Whiteman, K. R., & Torchilin, V. P. (1998) · Pharmaceutical Research · doi:10.1023/a:1011951016118 · Cited by 170
A novel approach using functional peptides for efficient intestinal absorption of insulin
Morishita, M., Kamei, N., Ehara, J., Isowa, K., & Takayama, K. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.12.022 · Cited by 165
Cell-penetrating peptides—A brief introduction
Järver, P., & Langel, Ü. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.02.012 · Cited by 165
Akita, H., Kogure, K., Moriguchi, R., Nakamura, Y., Higashi, T., Nakamura, T., Serada, S., Fujimoto, M., Naka, T., & Futaki, S. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.012 · Cited by 164
Anderberg, E. K., & Artursson, P. (1993) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600820412 · Cited by 164
Delivery of Biotherapeutics by Inhalation Aerosol
Niven, R. W. (1995) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v12.i2-3.20 · Cited by 163
Hydrogels for oral delivery of therapeutic proteins
Peppas, N. A., Wood, K. M., & Blanchette, J. O. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.6.881 · Cited by 161
Design of gelatin nanoparticles as swelling controlled delivery system for chloroquine phosphate
Bajpai, A. K., & Choubey, J. (2006) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-006-8235-9 · Cited by 161
New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin
GARCIAFUENTES, M., TORRES, D., & ALONSO, M. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.12.030 · Cited by 161
Kourtesi, C., Ball, A. R., Huang, Y.-Y., Jachak, S. M., Vera, D. M. A., Khondkar, P., Gibbons, S., Hamblin, M. R., & Tegos, G. P. (2013) · The Open Microbiology Journal · doi:10.2174/1874285801307010034 · Cited by 159
Polymers for Mucoadhesive Drug Delivery System: A Current Status
Asane, G. S., Nirmal, S. A., Rasal, K. B., Naik, A. A., Mahadik, M. S., & Rao, Y. M. (2008) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040802026012 · Cited by 159
Nanoparticles Toxicity and Their Routes of Exposures
Aydn, A., Sipahi, H., & Charehsaz, M. (2012) · Recent Advances in Novel Drug Carrier Systems · doi:10.5772/51230 · Cited by 158
Iwanaga, K., Ono, S., Narioka, K., Kakemi, M., Morimoto, K., Yamashita, S., Namba, Y., & Oku, N. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980235x · Cited by 157
Sakai, M., Imai, T., Ohtake, H., Azuma, H., & Otagiri, M. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960529n · Cited by 149
Protective roles of matrix metalloproteinases: From mouse models to human cancer
López-Otín, C., Palavalli, L. H., & Samuels, Y. (2009) · Cell Cycle · doi:10.4161/cc.8.22.9956 · Cited by 142
Prchla, E., Plank, C., Wagner, E., Blaas, D., & Fuchs, R. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.131.1.111 · Cited by 142
Traveling the Vitamin B12 Pathway: Oral Delivery of Protein and Peptide Drugs
Petrus, A. K., Fairchild, T. J., & Doyle, R. P. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200800865 · Cited by 141
Modulation of protein aggregation by polyethylene glycol conjugation: GCSF as a case study
Rajan, R. S., Li, T., Aras, M., Sloey, C. J., Sutherland, W., Arai, H., Briddell, R. A., Kinstler, O. B., Lueras, A. M. K., Zhang, Y., et al. (2006) · Protein Science · doi:10.1110/ps.052004006 · Cited by 140
Dissolving polymeric microneedle arrays for electrically assisted transdermal drug delivery
Garland, M. J., Caffarel–Salvador, E., Migalska, K., Woolfson, A. D., & Donnelly, R. F. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.003 · Cited by 139
Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery
Rajapaksa, T. E., Stover-Hamer, M., Fernandez, X., Eckelhoefer, H. A., & Lo, D. D. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.033 · Cited by 137
Endosomal Escape Pathways for Non-Viral Nucleic Acid Delivery Systems
Liang, W., & Lam, J. K. W. (2012) · InTech eBooks · doi:10.5772/46006 · Cited by 137
Nanoparticle-Mediated Cytoplasmic Delivery of Proteins To Target Cellular Machinery
Bale, S. S., Kwon, S., Shah, D. A., Banerjee, A., Dordick, J. S., & Kane, R. S. (2010) · ACS Nano · doi:10.1021/nn901586e · Cited by 133
Gratieri, T., Alberti, I., Lapteva, M., & Kalia, Y. N. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.03.019 · Cited by 133
Pathways followed by protein toxins into cells
Sandvig, K., Spilsberg, B., Lauvrak, S. U., Torgersen, M. L., Iversen, T., & van Deurs, B. O. (2004) · International Journal of Medical Microbiology · doi:10.1078/1438-4221-00294 · Cited by 130
Cell-penetrating TAT peptide in drug delivery systems: Proteolytic stability requirements
Koren, E., Apte, A., Sawant, R. R., Grunwald, J., & Torchilin, V. P. (2011) · Drug Delivery · doi:10.3109/10717544.2011.567310 · Cited by 127
Reversible lipidization for the oral delivery of salmon calcitonin
Wang, J., Chow, D. D., Heiati, H., & Shen, W. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00008-7 · Cited by 125
A lipocentric view of peptide-induced pores
Fuertes, G., Giménez, D., Esteban-Martín, S., Sánchez‐Muñoz, O. L., & Salgado, J. (2011) · European Biophysics Journal · doi:10.1007/s00249-011-0693-4 · Cited by 123
Absorption of protein via the intestinal wall
Ziv, E., Lior, O., & Kidron, M. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90411-4 · Cited by 120
Kamei, N., Morishita, M., & Takayama, K. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.02.015 · Cited by 119
Noninvasive routes of proteins and peptides drug delivery.
jitendra, Sharma, P. K., Bansal, S., & Banik, A. (2011) · PubMed Central · doi:10.4103/0250-474x.95608 · Cited by 118
Dipeptidyl Arylamidase II of the Pituitary
McDonald, J. K., Reilly, T. J., Zeitman, B. B., & Ellis, S. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93545-3 · Cited by 115
Development and in vivo evaluation of an oral insulin–PEG delivery system
Calceti, P., Salmaso, S., Walker, G. F., & Bernkop‐Schnürch, A. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.03.015 · Cited by 114
Fujii, S., Yokoyama, T., Ikegaya, K., Sato, F., & Yokoo, N. (1985) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1985.tb03064.x · Cited by 111
Interaction of the P-glycoprotein Multidrug Transporter with Peptides and Ionophores
Sharom, F. J., DiDiodato, G., Yu, X., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.17.10334 · Cited by 108
Werle, M., & Takeuchi, H. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.11.013 · Cited by 107
GAO, H., WANG, Y., FAN, Y., & MA, J. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.06.010 · Cited by 106
Nanoparticles toxicity and their routes of exposures.
Yah, C. S., Simate, G. S., & Iyuke, S. E. (2012) · PubMed · Cited by 106
Eiamtrakarn, S., Itoh, Y., Kishimoto, J.-I., Yoshikawa, Y., Shibata, N., Murakami, M., & Takada, K. (2002) · Biomaterials · doi:10.1016/s0142-9612(01)00089-8 · Cited by 103
Overcoming poor permeability: translating permeation enhancers for oral peptide delivery
Maher, S., & Brayden, D. J. (2011) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2011.11.006 · Cited by 103
Kwon, E. J., Bergen, J. M., & Pun, S. H. (2008) · Bioconjugate Chemistry · doi:10.1021/bc700448h · Cited by 103
Developments in the area of bioadhesive drug delivery systems
Lehr, C., & Haas, J. (2002) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2.3.287 · Cited by 100
Jain, M., Chauhan, S. C., Singh, A. P., Venkatraman, G., Colcher, D. M., & Batra, S. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0662 · Cited by 98
Tight Junctions: Molecular Structure Meets Function
Schulzke, J., & Fromm, M. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04925.x · Cited by 84
Engineering strategies to enhance nanoparticle-mediated oral delivery
Yamanaka, Y. J., & Leong, K. W. (2008) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856208786440479 · Cited by 81
On the Gene Delivery Efficacies of pH-Sensitive Cationic Lipids via Endosomal Protonation
Singh, R. S., Gonçalves, C., Sandrin, P., Pichon, C., Midoux, P., & Chaudhuri, A. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.03.026 · Cited by 74
Ablative Fractional Resurfacing in Topical Drug Delivery: An Update and Outlook
Bloom, B. S., Brauer, J. A., & Geronemus, R. G. (2013) · Dermatologic Surgery · doi:10.1111/dsu.12111 · Cited by 71
To PEGylate or not to PEGylate, that is not the question
Park, K. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.025 · Cited by 70
Polyethylene Glycol Nephrotoxicity Secondary to Prolonged High-Dose Intravenous Lorazepam
Laine, G. A., Hossain, S. H., Solis, R. T., & Adams, S. C. (1995) · Annals of Pharmacotherapy · doi:10.1177/106002809502901107 · Cited by 68
Cell penetrating peptide-mediated systemic siRNA delivery to the liver
Hayashi, Y., Yamauchi, J., Khalil, I. A., Kajimoto, K., Akita, H., & Harashima, H. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.07.038 · Cited by 66
Intravail™: highly effective intranasal delivery of peptide and protein drugs
Maggio, E. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.4.529 · Cited by 66
Kimura, T., & Ohyama, A. (1988) · Journal of General Virology · doi:10.1099/0022-1317-69-6-1247 · Cited by 65
Fatty acids as therapeutic auxiliaries for oral and parenteral formulations
Hackett, M., Zaro, J. L., Shen, W., Guley, P. C., & Cho, M. J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.07.012 · Cited by 62
Synthetic polymers for biopharmaceutical delivery
Magnusson, J. P., Saeed, A. O., Fernández‐Trillo, F., & Alexander, C. (2010) · Polymer Chemistry · doi:10.1039/c0py00210k · Cited by 62
Ducat, E., Deprez, J., Gillet, A., Noël, A., Évrard, B., Peulen, O., & Piel, G. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.08.034 · Cited by 61
Peptide and protein transdermal drug delivery
Herwadkar, A., & Banga, A. K. (2011) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2011.11.007 · Cited by 59
Prodrugs of Peptides. 18. Synthesis and Evaluation of Various Esters of Desmopressin (dDAVP)
Kahns, A. H., Buur, A., & Bundgaard, H. (1993) · Pharmaceutical Research · doi:10.1023/a:1018973029651 · Cited by 57
Combinatorial Targeting of the Macropinocytotic Pathway in Leukemia and Lymphoma Cells
Nishimura, S., Takahashi, S., Kamikatahira, H., Kuroki, Y., Jaalouk, D. E., O'Brien, S. M., Koivunen, E., Arap, W., Pasqualini, R., Nakayama, H., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708849200 · Cited by 57
Buur, A., & Bundgaard, H. (1988) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(88)90021-x · Cited by 53
SONG, K., FASANO, A., & Eddington, N. D. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.09.011 · Cited by 53
Tu, Y., & Kim, J. (2008) · The Journal of Gene Medicine · doi:10.1002/jgm.1184 · Cited by 52
Proapoptotic Activity of Cell-Permeable Anti-Akt Single-Chain Antibodies
Shin, I., Edl, J., Biswas, S., Lin, P. C., Mernaugh, R. L., & Arteaga, C. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2898 · Cited by 51
Baas, T. C., & Thacker, P. A. (1996) · Canadian Journal of Animal Science · doi:10.4141/cjas96-036 · Cited by 48
Steinert, R. E., Poller, B., Castelli, M., Friedman, K., Huber, A., Drewe, J., & Beglinger, C. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.159 · Cited by 47
Why is Exubera being withdrawn?
Bailey, C. J., & Barnett, A. H. (2007) · BMJ · doi:10.1136/bmj.39409.507662.94 · Cited by 47
The Impact of ΔG on the Oral Bioavailability of Low Bioavailable Therapeutic Agents
Salama, N. N., Fasano, A., Thakar, M., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.073205 · Cited by 45
Cook, C. S., Karabatsos, P. J., Schoenhard, G. L., & Karim, A. (1995) · Pharmaceutical Research · doi:10.1023/a:1016259826037 · Cited by 40
Samadi, N., van Nostrum, C. F., Vermonden, T., Amidi, M., & Hennink, W. E. (2013) · Biomacromolecules · doi:10.1021/bm301900t · Cited by 40
Knarreborg, A., Jensen, S. K., & Engberg, R. M. (2003) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(03)00008-1 · Cited by 39
Transdermal delivery of human epidermal growth factor facilitated by a peptide chaperon
Ruan, R., Wang, S., Wang, C., et al. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.12.054 · Cited by 32
Insight of current technologies for oral delivery of proteins and peptides
Chin, J., Mahmud, F., Kim, S. E., Park, K., & Byun, Y. (2012) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2012.04.005 · Cited by 32
Three Generations: The Past, Present, and Future of Transdermal Drug Delivery Systems
Wilson, E. J. (2014) · Cited by 20
Membrane destabilization by ricin
Sun, J., Pohl, E. E., Krylova, O. O., Krause, E., Agapov, I. I., Tonevitsky, A., & Pohl, P. (2004) · European Biophysics Journal · doi:10.1007/s00249-004-0400-9 · Cited by 19
Rectal drug delivery: A promising route for enhancing drug absorption
Prasanna, J. L., Deepthi, B., & Rao, N. R. (2012) · Cited by 19
Cited by
Artificial intelligence to deep learning: machine intelligence approach for drug discovery
Gupta, R., Srivastava, D., Sahu, M., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10217-3 · Cited by 1,473
“Peptides are a biologically active small chain of around 2–50 amino acids, which are increasingly being explored for therapeutic purposes as they have the ability to cross the cellular barrier and can reach the desired target site [109].”
BackgroundInsight into Cellular Uptake and Intracellular Trafficking of Nanoparticles
Foroozandeh, P., & Aziz, A. A. (2018) · Nanoscale Research Letters · doi:10.1186/s11671-018-2728-6 · Cited by 1,377
The evolution of commercial drug delivery technologies
Vargason, A. M., Anselmo, A. C., & Mitragotri, S. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00698-w · Cited by 1,361
The Current State of Peptide Drug Discovery: Back to the Future?
Henninot, A., Collins, J. C., & Nuss, J. M. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00318 · Cited by 1,113
Smart nanoparticles for cancer therapy
Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01642-x · Cited by 1,073
Metadata
- Authors
- Bruno, B. J., Miller, G. D., & Lim, C. S.
- Venue
- Therapeutic Delivery
- Publisher
- Informa UK Limited
- Published
- 2013-11
- Volume
- 4
- Issue
- 11
- Pages
- 1443-1467
- ISSN
- 2041-5990 (ISSN-L)
- 2041-6008
- OpenAlex
- W2109598625
- Cited by
- 754
- References
- 187
- FWCI
- 7.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.